ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A

Identifying genetic biomarkers of synthetic lethal drug sensitivity effects provides one approach to the development of targeted cancer therapies. Mutations in ARID1A represent one of the most common molecular alterations in human cancer, but therapeutic approaches that target these defects are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Chris T., Miller, Rowan, Pemberton, Helen N., Jones, Samuel E., Campbell, James, Konde, Asha, Badham, Nicholas, Rafiq, Rumana, Brough, Rachel, Gulati, Aditi, Ryan, Colm J., Francis, Jeff, Vermulen, Peter B., Reynolds, Andrew R., Reaper, Philip M., Pollard, John R., Ashworth, Alan, Lord, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159945/
https://www.ncbi.nlm.nih.gov/pubmed/27958275
http://dx.doi.org/10.1038/ncomms13837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159945/
https://www.ncbi.nlm.nih.gov/pubmed/27958275
http://dx.doi.org/10.1038/ncomms13837

Ejemplares similares